Cargando…
Angiotensin blockade therapy and survival in pancreatic cancer: a population study
BACKGROUND: Pancreatic cancer (PC) is one of the most aggressive and challenging cancer types to effectively treat, ranking as the fourth-leading cause of cancer death in the United States. We investigated if exposures to angiotensin II receptor blockers (ARBs) or angiotensin I converting enzyme (AC...
Autores principales: | Keith, Scott W., Maio, Vittorio, Arafat, Hwyda A., Alcusky, Matthew, Karagiannis, Thomas, Rabinowitz, Carol, Lavu, Harish, Louis, Daniel Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819908/ https://www.ncbi.nlm.nih.gov/pubmed/35130875 http://dx.doi.org/10.1186/s12885-022-09200-4 |
Ejemplares similares
-
Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011) -
Thymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation
por: Relles, Daniel, et al.
Publicado: (2016) -
Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion—Preliminary Observations
por: Sarosiek, Konrad, et al.
Publicado: (2016) -
Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021) -
Angiotensin-receptor blockade in acute stroke
por: Rajendran, Srijithesh P.
Publicado: (2011)